Supportive care of patients with fibrosing interstitial lung disease: answering a great clinical need

Fibrosing interstitial lung disease (F-ILD) significantly reduces quality of life. F-ILD care includes symptom management, end-of-life planning and supportive measures, as well as antifibrotics. Patients and carers should be central to all care decisions. https://bit.ly/2ZAE2Ks

Detalles Bibliográficos
Autores principales: Goodwin, Amanda T., Saini, Gauri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792811/
https://www.ncbi.nlm.nih.gov/pubmed/33447270
http://dx.doi.org/10.1183/20734735.0066-2020
Descripción
Sumario:Fibrosing interstitial lung disease (F-ILD) significantly reduces quality of life. F-ILD care includes symptom management, end-of-life planning and supportive measures, as well as antifibrotics. Patients and carers should be central to all care decisions. https://bit.ly/2ZAE2Ks

Ejemplares similares